vs
Side-by-side financial comparison of AETHLON MEDICAL INC (AEMD) and ALLURION TECHNOLOGIES, INC. (ALUR). Click either name above to swap in a different company.
ALLURION TECHNOLOGIES, INC. is the larger business by last-quarter revenue ($3.6M vs $60.0K, roughly 60.3× AETHLON MEDICAL INC). ALLURION TECHNOLOGIES, INC. runs the higher net margin — -167.0% vs -2926.4%, a 2759.4% gap on every dollar of revenue.
Aethlon Medical Inc. is a clinical-stage medical technology firm that develops targeted therapeutic devices to address life-threatening health conditions. Its lead product, the Hemopurifier, is designed to remove harmful viruses, cancer-derived exosomes, and other pathogens from the bloodstream. The company primarily operates in the infectious disease and oncology healthcare segments, with main market presence in North America.
Robinson Technologies is a Japanese video game developer founded by Seth Robinson. The company produced the BBS door games Legend of the Red Dragon, Planets: The Exploration of Space and Growtopia, an experimental multiplayer creative sandbox created as a collaboration with Hamumu Software, released in 2013 for iOS, Android, Microsoft Windows, and macOS.
AEMD vs ALUR — Head-to-Head
Income Statement — Q3 2025 vs Q4 2025
| Metric | | |
|---|---|---|
| Revenue | $60.0K | $3.6M |
| Net Profit | $-1.8M | $-6.0M |
| Gross Margin | — | 44.5% |
| Operating Margin | -3026.4% | -174.2% |
| Net Margin | -2926.4% | -167.0% |
| Revenue YoY | — | -35.4% |
| Net Profit YoY | 49.4% | 37.2% |
| EPS (diluted) | $-10.05 | $-0.69 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | — | $3.6M | ||
| Q3 25 | — | $2.7M | ||
| Q2 25 | — | $3.4M | ||
| Q1 25 | — | $5.6M | ||
| Q4 24 | $60.0K | $5.6M | ||
| Q3 24 | $95.1K | $5.4M | ||
| Q2 24 | — | $11.8M | ||
| Q1 24 | — | $9.4M |
| Q4 25 | — | $-6.0M | ||
| Q3 25 | — | $-11.9M | ||
| Q2 25 | — | $-9.3M | ||
| Q1 25 | — | $-1.5M | ||
| Q4 24 | $-1.8M | $-9.6M | ||
| Q3 24 | $-2.8M | $8.7M | ||
| Q2 24 | — | $-8.3M | ||
| Q1 24 | — | $2.0M |
| Q4 25 | — | 44.5% | ||
| Q3 25 | — | 49.1% | ||
| Q2 25 | — | 73.9% | ||
| Q1 25 | — | 74.6% | ||
| Q4 24 | — | 45.3% | ||
| Q3 24 | — | 58.0% | ||
| Q2 24 | — | 76.4% | ||
| Q1 24 | — | 73.2% |
| Q4 25 | — | -174.2% | ||
| Q3 25 | — | -362.3% | ||
| Q2 25 | — | -205.7% | ||
| Q1 25 | — | -130.5% | ||
| Q4 24 | -3026.4% | -306.2% | ||
| Q3 24 | -3050.2% | -229.9% | ||
| Q2 24 | — | -79.4% | ||
| Q1 24 | — | -121.4% |
| Q4 25 | — | -167.0% | ||
| Q3 25 | — | -447.1% | ||
| Q2 25 | — | -276.3% | ||
| Q1 25 | — | -26.9% | ||
| Q4 24 | -2926.4% | -171.8% | ||
| Q3 24 | -2950.2% | 162.8% | ||
| Q2 24 | — | -70.7% | ||
| Q1 24 | — | 21.3% |
| Q4 25 | — | $-0.69 | ||
| Q3 25 | — | $-1.53 | ||
| Q2 25 | — | $-1.28 | ||
| Q1 25 | — | $-0.31 | ||
| Q4 24 | $-10.05 | $-3.22 | ||
| Q3 24 | $-16.11 | $3.40 | ||
| Q2 24 | — | $-4.34 | ||
| Q1 24 | — | $0.96 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $4.8M | $5.4M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $4.3M | $-77.2M |
| Total Assets | $6.5M | $15.8M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | — | $5.4M | ||
| Q3 25 | — | $6.1M | ||
| Q2 25 | — | $12.7M | ||
| Q1 25 | — | $20.4M | ||
| Q4 24 | $4.8M | $15.4M | ||
| Q3 24 | $6.9M | $28.7M | ||
| Q2 24 | — | $19.3M | ||
| Q1 24 | — | $29.7M |
| Q4 25 | — | $-77.2M | ||
| Q3 25 | — | $-82.9M | ||
| Q2 25 | — | $-64.0M | ||
| Q1 25 | — | $-69.8M | ||
| Q4 24 | $4.3M | $-78.0M | ||
| Q3 24 | $6.0M | $-64.8M | ||
| Q2 24 | — | $-70.6M | ||
| Q1 24 | — | $-66.2M |
| Q4 25 | — | $15.8M | ||
| Q3 25 | — | $18.1M | ||
| Q2 25 | — | $28.2M | ||
| Q1 25 | — | $38.4M | ||
| Q4 24 | $6.5M | $32.8M | ||
| Q3 24 | $8.8M | $50.7M | ||
| Q2 24 | — | $46.5M | ||
| Q1 24 | — | $60.0M |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-2.0M | $-5.3M |
| Free Cash FlowOCF − Capex | $-2.0M | — |
| FCF MarginFCF / Revenue | -3357.0% | — |
| Capex IntensityCapex / Revenue | 3.7% | — |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | — | $-5.3M | ||
| Q3 25 | — | $-6.5M | ||
| Q2 25 | — | $-7.6M | ||
| Q1 25 | — | $-9.5M | ||
| Q4 24 | $-2.0M | $-13.3M | ||
| Q3 24 | $-2.2M | $-11.5M | ||
| Q2 24 | — | $-8.9M | ||
| Q1 24 | — | $-8.6M |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | $-2.0M | — | ||
| Q3 24 | — | $-11.5M | ||
| Q2 24 | — | $-9.4M | ||
| Q1 24 | — | $-8.7M |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | -3357.0% | — | ||
| Q3 24 | — | -214.9% | ||
| Q2 24 | — | -79.6% | ||
| Q1 24 | — | -93.1% |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | 3.7% | 0.0% | ||
| Q3 24 | 0.0% | 1.3% | ||
| Q2 24 | — | 3.7% | ||
| Q1 24 | — | 1.1% |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | -1.31× | ||
| Q2 24 | — | — | ||
| Q1 24 | — | -4.33× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
